A detailed history of Central Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Central Trust CO holds 7,068 shares of NVS stock, worth $684,394. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,068
Previous 7,386 4.31%
Holding current value
$684,394
Previous $786,000 3.31%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$106.13 - $120.89 $33,749 - $38,443
-318 Reduced 4.31%
7,068 $812,000
Q2 2024

Aug 05, 2024

SELL
$92.57 - $107.37 $23,049 - $26,735
-249 Reduced 3.26%
7,386 $786,000
Q1 2024

Apr 24, 2024

SELL
$95.27 - $108.47 $48,587 - $55,319
-510 Reduced 6.26%
7,635 $738,000
Q4 2023

Jan 24, 2024

BUY
$92.27 - $101.54 $6,458 - $7,107
70 Added 0.87%
8,145 $822,000
Q3 2023

Oct 26, 2023

SELL
$94.73 - $105.13 $663 - $735
-7 Reduced 0.09%
8,075 $822,000
Q2 2023

Jul 26, 2023

BUY
$92.52 - $104.91 $32,844 - $37,243
355 Added 4.59%
8,082 $815,000
Q1 2023

Apr 19, 2023

BUY
$80.03 - $92.81 $21,608 - $25,058
270 Added 3.62%
7,727 $710,000
Q4 2022

Jan 26, 2023

BUY
$75.55 - $92.52 $5,741 - $7,031
76 Added 1.03%
7,457 $0
Q3 2022

Nov 17, 2022

SELL
$74.61 - $87.26 $48,048 - $56,195
-644 Reduced 8.02%
7,381 $561,000
Q2 2022

Aug 09, 2022

SELL
$80.52 - $93.75 $40,260 - $46,875
-500 Reduced 5.87%
8,025 $678,000
Q1 2022

May 03, 2022

BUY
$80.11 - $90.62 $10,894 - $12,324
136 Added 1.62%
8,525 $748,000
Q4 2021

Feb 08, 2022

SELL
$79.7 - $88.13 $7,491 - $8,284
-94 Reduced 1.11%
8,389 $733,000
Q3 2021

Oct 19, 2021

SELL
$81.78 - $95.14 $16,356 - $19,028
-200 Reduced 2.3%
8,483 $693,000
Q2 2021

Jul 23, 2021

BUY
$85.24 - $94.15 $17,048 - $18,830
200 Added 2.36%
8,683 $792,000
Q1 2021

Apr 23, 2021

SELL
$83.5 - $98.47 $156,479 - $184,532
-1,874 Reduced 18.09%
8,483 $725,000
Q4 2020

Jan 29, 2021

SELL
$78.07 - $94.43 $35,990 - $43,532
-461 Reduced 4.26%
10,357 $978,000
Q3 2020

Oct 22, 2020

SELL
$82.14 - $91.0 $156,394 - $173,264
-1,904 Reduced 14.97%
10,818 $940,000
Q2 2020

Jul 14, 2020

SELL
$80.93 - $91.1 $39,331 - $44,274
-486 Reduced 3.68%
12,722 $1.11 Million
Q1 2020

Apr 17, 2020

BUY
$70.67 - $99.01 $44,027 - $61,683
623 Added 4.95%
13,208 $1.09 Million
Q4 2019

Jan 21, 2020

BUY
$84.35 - $95.37 $168,446 - $190,453
1,997 Added 18.86%
12,585 $1.19 Million
Q3 2019

Oct 28, 2019

BUY
$85.54 - $94.26 $62,273 - $68,621
728 Added 7.38%
10,588 $920,000
Q2 2019

Jul 12, 2019

BUY
$75.4 - $92.8 $21,112 - $25,984
280 Added 2.92%
9,860 $0
Q1 2019

Apr 26, 2019

BUY
$75.32 - $86.15 $1,506 - $1,723
20 Added 0.21%
9,580 $0
Q4 2018

Jan 08, 2019

SELL
$73.66 - $82.02 $19,888 - $22,145
-270 Reduced 2.75%
9,560 $735,000
Q3 2018

Oct 04, 2018

SELL
$66.94 - $77.43 $6,158 - $7,123
-92 Reduced 0.93%
9,830 $0
Q2 2018

Jul 09, 2018

SELL
$64.91 - $73.36 $209,140 - $236,365
-3,222 Reduced 24.51%
9,922 $0
Q1 2018

Apr 04, 2018

BUY
$70.39 - $84.15 $226,233 - $270,458
3,214 Added 32.37%
13,144 $0
Q4 2017

Jan 23, 2018

SELL
$72.33 - $77.64 $61,625 - $66,149
-852 Reduced 7.9%
9,930 $0
Q3 2017

Oct 17, 2017

BUY
$74.14 - $77.27 $799,377 - $833,125
10,782
10,782 $0

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $208B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.